Lastly, we demonstrate that XRN2 alters the transcriptional profile of GBM cells, suggesting that XRN2 can mediate the expression of cellular factors for cell motility and invasion in GBMs similar to the observations in lung cancer [13]. This evidence concerns the gene XRN2 and glioblastoma.